The Hain Celestial Group, Inc. (HAIN) 10-Q 22 Jun 17 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2016	Jun. 16, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Trading Symbol	HAIN
Entity Registrant Name	HAIN CELESTIAL GROUP INC.
Entity Central Index Key	910,406
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		103,697,237

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 157,125	$ 127,926
Accounts receivable, less allowance for doubtful accounts of $715 and $936, respectively	250,581	278,933
Inventories	430,578	408,564
Prepaid expenses and other current assets	64,105	84,811
Total current assets	902,389	900,234
Property, plant and equipment, net	372,082	389,841
Goodwill	1,027,660	1,060,336
Trademarks and other intangible assets, net	567,906	604,787
Investments and joint ventures	19,047	20,244
Other assets	31,858	32,638
Total assets	2,920,942	3,008,080
Current liabilities:
Accounts payable	261,037	251,712
Accrued expenses and other current liabilities	98,026	78,803
Current portion of long-term debt	12,369	26,513
Total current liabilities	371,432	357,028
Long-term debt, less current portion	790,691	836,171
Deferred income taxes	124,397	131,507
Other noncurrent liabilities	17,190	18,860
Total liabilities	1,303,710	1,343,566
Commitments and contingencies
Stockholders’ equity:
Preferred stock - $.01 par value, authorized: 5,000 shares; issued and outstanding: none	0	0
Common stock - $.01 par value, authorized: 150,000 shares; issued: 107,966 and 107,479 shares, respectively; outstanding: 103,687 and 103,461 shares, respectively	1,080	1,075
Additional paid-in capital	1,133,485	1,123,206
Retained earnings	837,181	801,392
Accumulated other comprehensive loss	(255,533)	(172,111)
Total stockholders' equity including treasury stock	1,716,213	1,753,562
Less: Treasury stock, at cost: 4,279 and 4,018 shares, respectively	(98,981)	(89,048)
Total stockholders’ equity	1,617,232	1,664,514
Total liabilities and stockholders’ equity	$ 2,920,942	$ 3,008,080

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 715	$ 936
Preferred stock, par value (USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (shares)	5,000,000	5,000,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	150,000,000	150,000,000
Common stock, shares issued (shares)	107,966,000	107,479,000
Common stock, shares outstanding (shares)	103,687,000	103,461,000
Treasury stock, shares (shares)	4,279,000	4,018,000

Consolidated Statements Of Inco

Consolidated Statements Of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Net sales	$ 739,999	$ 1,421,463	$ 1,411,164
Cost of sales	601,606	1,173,203	1,107,022
Gross profit	138,393	248,260	304,142
Selling, general and administrative expenses	85,187	170,154	144,531
Amortization of acquired intangibles	4,693	9,421	9,343
Acquisition related expenses, restructuring and integration charges and other	108	568	5,918
Accounting review costs	7,005	12,966	0
Operating income	41,400	55,151	144,350
Interest and other financing expense, net	5,097	10,178	12,767
Other (income)/expense, net	(1,353)	(1,865)	8,466
Income before income taxes and equity in net (income) loss of equity-method investees	37,656	46,838	123,117
Provision for income taxes	10,509	11,271	35,932
Equity in net (income) loss of equity-method investees	(38)	(222)	(53)
Net income	$ 27,185	$ 35,789	$ 87,238
Net income per common share:
Basic (USD per share)	$ 0.26	$ 0.35	$ 0.85
Diluted (USD per share)	$ 0.26	$ 0.34	$ 0.84
Weighted average common shares outstanding:
Basic (shares)	103,597	103,532	102,912
Diluted (shares)	104,204	104,225	104,209

Consolidated Statements Of Comp

Consolidated Statements Of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 27,185	$ 58,080	$ 35,789	$ 87,238
Pre-tax amount
Foreign currency translation adjustments, before tax	(51,222)	(25,655)	(82,958)	(65,587)
Change in deferred gains (losses) on cash flow hedging instruments, before tax	(13)	(418)	(443)	1,322
Change in unrealized gain (loss) on available for sale investment, before tax	(32)	39	(89)	(216)
Total other comprehensive income (loss), before tax	(51,267)	(26,034)	(83,490)	(64,481)
Tax (expense) benefit
Foreign currency translation adjustments, tax	0	0	0	0
Change in deferred gains (losses) on cash flow hedging instruments tax	3	122	38	(277)
Change in unrealized gain (loss) on available for sale investment, tax	13	(15)	30	84
Total other comprehensive income (loss), tax	16	107	68	(193)
Other comprehensive income (loss):
Foreign currency translation adjustments, net of tax	(51,222)	(25,655)	(82,958)	(65,587)
Change in deferred gains (losses) on cash flow hedging instruments, net of tax	(10)	(296)	(405)	1,045
Change in unrealized gain (loss) on available for sale investment, net of tax	(19)	24	(59)	(132)
Net change in accumulated other comprehensive loss	(51,251)	(25,927)	(83,422)	(64,674)
Total comprehensive (loss) income	$ (24,066)	$ 32,153	$ (47,633)	$ 22,564

Consolidated Statement Of Stock

Consolidated Statement Of Stockholders' Equity (Unaudited) - 6 months ended Dec. 31, 2016 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Jun. 30, 2016	$ 1,664,514	$ 1,075	$ 1,123,206	$ 801,392	$ (89,048)	$ (172,111)
Balance, shares at Jun. 30, 2016	107,479	107,479			4,018
Stockholders' Equity [Roll Forward]
Net income	$ 35,789			35,789
Other comprehensive loss	(83,422)					(83,422)
Issuance of common stock pursuant to stock based compensation plans	0	$ 5	1,994		$ (1,999)
Issuance of common stock pursuant to stock based compensation plans, shares		487			2
Stock based compensation income tax effects	3,050		3,050
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans	(7,934)				$ (7,934)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans, shares					259
Stock based compensation expense	5,235		5,235
Balance at Dec. 31, 2016	$ 1,617,232	$ 1,080	$ 1,133,485	$ 837,181	$ (98,981)	$ (255,533)
Balance, shares at Dec. 31, 2016	107,966	107,966			4,279

Consolidated Statement Of Stoc7

Consolidated Statement Of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	Dec. 31, 2016	Jun. 30, 2016
Statement of Stockholders' Equity [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 35,789	$ 87,238
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	34,168	31,790
Deferred income taxes	(5,300)	(8,848)
Equity in net income of equity-method investees	(222)	(53)
Stock based compensation	5,235	7,229
Other non-cash items including unrealized foreign currency (gains)/losses, net	(3,184)	7,812
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable	15,885	(18,412)
Inventories	(31,921)	(18,293)
Other current assets	20,854	26,147
Other assets and liabilities	(1,038)	2,187
Accounts payable and accrued expenses	42,547	(17,153)
Net cash provided by operating activities	112,813	99,644
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisitions of businesses, net of cash acquired and working capital settlements	0	(157,061)
Purchases of property and equipment	(28,725)	(41,177)
Proceeds from sale of business	5,419	0
Other	1,000	0
Net cash used in investing activities	(22,306)	(198,238)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	22,000	152,049
Repayments under bank revolving credit facility	(56,500)	(30,080)
Borrowings (repayments) of other debt, net	(13,690)	780
Excess tax benefits from stock based compensation	3,314	2,016
Acquisition related contingent consideration	(2,498)	0
Shares withheld for payment of employee payroll taxes	(7,934)	(10,434)
Net cash (used in) provided by financing activities	(55,308)	114,331
Effect of exchange rate changes on cash	(6,000)	(5,559)
Net increase in cash and cash equivalents	29,199	10,178
Cash and cash equivalents at beginning of period	127,926	166,922
Cash and cash equivalents at end of period	$ 157,125	$ 177,100

Business

Business	6 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	BUSINESS The Hain Celestial Group, Inc., a Delaware corporation, and its subsidiaries (collectively, “Hain Celestial” or the “Company,” and herein referred to as “we,” “us,” and “our”) was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — to be the leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide. With a proven track record of strategic growth and profitability, the Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of Life TM . Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream ® , Arrowhead Mills ® , Bearitos ® , BluePrint ® , Celestial Seasonings ® , Coconut Dream ® , Cully & Sully ® , Danival ® , DeBoles ® , Earth’s Best ® , Ella’s Kitchen ® , Empire ® , Europe’s Best ® , Farmhouse Fare ® , Frank Cooper’s ® , FreeBird ® , Gale’s ® , Garden of Eatin’ ® , GG UniqueFiber TM , Hain Pure Foods ® , Hartley’s ® , Health Valley ® , Imagine ® , Johnson’s Juice Co. ® , Joya ® , Kosher Valley ® , Lima ® , Linda McCartney’s ® (under license), MaraNatha ® , Natumi ® , New Covent Garden Soup Co. ® , Plainville Farms ® , Rice Dream ® , Robertson’s ® , Rudi’s Gluten-Free Bakery ® , Rudi’s Organic Bakery ® , Sensible Portions ® , Spectrum Organics ® , Soy Dream ® , Sun-Pat ® , SunSpire ® , Terra ® , The Greek Gods ® , Tilda ® , WestSoy ® and Yves Veggie Cuisine ® . The Company’s personal care products are marketed under the Alba Botanica ® , Avalon Organics ® , Earth’s Best ® , JASON ® , Live Clean ® and Queen Helene ® brands. During fiscal year 2016, the Company commenced a strategic review, which it called “Project Terra,” that resulted in the Company redefining its core platforms, starting with the United States segment, for future growth based upon consumer trends to create and inspire A Healthier Way of Life™. In addition, beginning in fiscal year 2017, the Company launched Cultivate Ventures (“Cultivate”), a venture unit with a threefold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories such as BluePrint ® cold-pressed juices, SunSpire ® chocolates and DeBoles ® pasta by giving those products a dedicated, creative focus for refresh and relaunch; (ii) to incubate small acquisitions until they reach the scale for the Company’s core platforms; and (iii) to invest in concepts, products and technology that focus on health and wellness. See Note 16, Segment Information , for information on the Company’s operating and reportable segments and the effect the formation of Cultivate had thereon.

Basis of Presentation

Basis of Presentation	6 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Basis of Presentation	BASIS OF PRESENTATION The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP. The amounts as of and for the periods ended June 30, 2016 are derived from the Company’s audited annual financial statements. The consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the three and six months ended December 31, 2016 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2017. Please refer to the notes to the Consolidated Financial Statements as of June 30, 2016 and for the fiscal year then ended included in the Company’s Annual Report on Form 10-K (the “Form 10-K”) for information not included in these condensed notes. All amounts in the consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated. Recently Issued Accounting Pronouncements Not Yet Effective Summary of Significant Accounting Policies and Practices , in the Notes to the Consolidated Financial Statements as of June 30, 2016 and for the fiscal year then ended included in the Form 10-K for a detailed discussion on recently issued accounting pronouncements not yet adopted by the Company. There has been no change to the statements made in the Form 10-K as of the date of filing of this Form 10-Q.

Correction of Immaterial Errors

Correction of Immaterial Errors To Prior Period Financial Statements	6 Months Ended
	Dec. 31, 2016
Accounting Changes and Error Corrections [Abstract]
Correction of Immaterial Errors To Prior Period Financial Statements	CORRECTION OF IMMATERIAL ERRORS TO PRIOR PERIOD FINANCIAL STATEMENTS Accounting Review During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate the Company’s internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. On November 16, 2016, the Company announced that the independent review of the Audit Committee was completed and that the review found no evidence of intentional wrongdoing in connection with the preparation of the Company’s financial statements. The aforementioned reviews identified material weaknesses in our internal control over financial reporting. Refer to “Part I, Item 4. Controls and Procedures” of the Form 10-Q for a description of these material weaknesses and management’s plan and implementation of remediation efforts to address these material weaknesses. Although the initial focus of the Company’s internal accounting review discussed above pertained to the evaluation of the timing of the recognition of the revenue associated with the practice of granting additional concessions to certain distributors, the Company subsequently expanded its internal accounting review and performed an analysis of previously-issued financial statements in order to identify and assess other potential errors. Based upon this review, the Company identified certain immaterial errors relating to its previously-issued financial statements which resulted in revisions to our previously-issued financial statements. Accordingly, prior period amounts presented in the consolidated financial statements and the related notes have been revised (referred to as the “Revision”). All costs incurred in connection with the internal accounting review, the Audit Committee’s independent review and related matters are included in “Accounting review costs” in the Company’s Consolidated Statements of Income. Based on an analysis of Accounting Standards Codification (“ASC”) 250 - “Accounting Changes and Error Corrections” (“ASC 250”), Staff Accounting Bulletin 99 - “Materiality” (“SAB 99”) and Staff Accounting Bulletin 108 - Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”), the Company determined that these errors were immaterial to the previously-issued financial statements; however, a cumulative correction of these errors would have had a material impact on the financial results for the three and twelve months ended June 30, 2016. Accordingly, we have revised our presentation of certain amounts in the consolidated financial statements for the three and six months ended December 31, 2015 to reflect such corrections as if they had been recorded in the appropriate fiscal period. We refer the reader to the Company’s Form 10-K for the fiscal year ended June 30, 2016 for a detailed explanation of the immaterial errors. Revised Financial Statements The impact of the Revision on the Company’s previously-issued financial statements is illustrated in the tables below. Amounts throughout the consolidated financial statements and notes thereto have been adjusted to incorporate the revised amounts, where applicable. CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Three Months Ended December 31, 2015 As Reported Adjustment As Revised Net sales $ 752,589 $ (9,152 ) $ 743,437 Cost of sales 575,026 2,150 577,176 Gross profit 177,563 (11,302 ) 166,261 Selling, general and administrative expenses 82,607 (13,626 ) 68,981 Amortization of acquired intangibles 4,736 (32 ) 4,704 Acquisition related expenses, restructuring and integration charges and other 2,498 — 2,498 Operating income 87,722 2,356 90,078 Interest and other financing expense, net 6,300 — 6,300 Other (income)/expense, net 3,065 — 3,065 Income before income taxes and equity in earnings of equity- method investees 78,357 2,356 80,713 Provision for income taxes 21,379 1,223 22,602 Equity in net loss of equity-method investees 31 — 31 Net income $ 56,947 $ 1,133 $ 58,080 Net income per common share: Basic $ 0.55 $ 0.01 $ 0.56 Diluted $ 0.55 $ 0.01 $ 0.56 Weighted average common shares outstanding: Basic 103,017 103,017 103,017 Diluted 104,161 104,161 104,161 * Net income per common share may not add in certain periods due to rounding Six Months Ended December 31, 2015 As Reported Adjustment As Revised Net sales $ 1,439,777 $ (28,613 ) $ 1,411,164 Cost of sales 1,110,167 (3,145 ) 1,107,022 Gross profit 329,610 (25,468 ) 304,142 Selling, general and administrative expenses 168,861 (24,330 ) 144,531 Amortization/impairment of acquired intangibles 9,408 (65 ) 9,343 Acquisition related expenses, restructuring and integration charges and other 6,151 (233 ) 5,918 Operating income 145,190 (840 ) 144,350 Interest and other financing expense, net 12,767 — 12,767 Other (income)/expense, net 8,466 — 8,466 Income before income taxes and equity in earnings of equity- method investees 123,957 (840 ) 123,117 Provision for income taxes 35,761 171 35,932 Equity in net income of equity-method investees (53 ) — (53 ) Net income $ 88,249 $ (1,011 ) $ 87,238 Net income per common share: Basic $ 0.86 $ (0.01 ) $ 0.85 Diluted $ 0.85 $ (0.01 ) $ 0.84 Weighted average common shares outstanding: Basic 102,912 102,912 102,912 Diluted 104,209 104,209 104,209 * Net income per common share may not add in certain periods due to rounding CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Three Months Ended December 31, 2015 Six Months Ended December 31, 2015 As Reported Adjustment As Revised As Reported Adjustment As Revised Net income $ 56,947 $ 1,133 $ 58,080 $ 88,249 $ (1,011 ) $ 87,238 Other comprehensive income (loss): Foreign currency translation adjustments $ (25,791 ) $ 136 (25,655 ) $ (66,084 ) 497 (65,587 ) Change in deferred gains (losses) on cash flow hedging instruments (296 ) — (296 ) 1,045 — 1,045 Change in unrealized gain (loss) on available for sale investment 24 — 24 (132 ) — (132 ) Total other comprehensive income (loss) $ (26,063 ) $ 136 $ (25,927 ) $ (65,171 ) $ 497 $ (64,674 ) Total comprehensive income $ 30,884 $ 1,269 $ 32,153 $ 23,078 $ (514 ) $ 22,564 CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Six Months Ended December 31, 2015 As Reported Adjustment As Revised CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 88,249 $ (1,011 ) $ 87,238 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 31,409 381 31,790 Deferred income taxes (8,693 ) (155 ) (8,848 ) Equity in net income of equity-method investees (53 ) — (53 ) Stock based compensation 7,229 — 7,229 Other non-cash items, including unrealized currency (gains)/loss, net 7,812 — 7,812 Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions: Accounts receivable (17,231 ) (1,181 ) (18,412 ) Inventories (20,891 ) 2,598 (18,293 ) Other current assets 5,336 20,811 26,147 Other assets and liabilities 2,187 — 2,187 Accounts payable and accrued expenses 4,290 (21,443 ) (17,153 ) Net cash provided by operating activities $ 99,644 $ — $ 99,644 There were no adjustments to cash balances and to cash flows from investing and financing activities for the six months ended December 31, 2015 as a result of the Revision. SEGMENT NET SALES AND OPERATING INCOME (UNAUDITED) Three Months Ended December 31, 2015 As Reported (1) Adjustment As Revised Net Sales: United States $ 322,878 $ (8,193 ) $ 314,685 United Kingdom 194,226 (2,972 ) 191,254 Hain Pure Protein 141,706 2,486 144,192 Rest of World 93,779 (473 ) 93,306 $ 752,589 $ (9,152 ) $ 743,437 Operating Income: United States $ 48,315 $ 2,625 $ 50,940 United Kingdom 18,768 (343 ) 18,425 Hain Pure Protein 18,125 37 18,162 Rest of World 6,595 496 7,091 $ 91,803 $ 2,815 $ 94,618 Corporate and Other (4,081 ) (459 ) (4,540 ) $ 87,722 $ 2,356 $ 90,078 (1) The information previously reported for the three months ended December 31, 2015 has been adjusted to reflect the Company’s new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment Information, for additional details surrounding the formation of Cultivate. Six Months Ended December 31, 2015 As Reported (1) Adjustment As Revised Net Sales: United States $ 637,464 $ (20,148 ) $ 617,316 United Kingdom 359,580 (7,471 ) 352,109 Hain Pure Protein 265,694 1,553 267,247 Rest of World 177,039 (2,547 ) 174,492 $ 1,439,777 $ (28,613 ) $ 1,411,164 Operating Income: United States $ 92,203 $ 244 $ 92,447 United Kingdom 28,972 (705 ) 28,267 Hain Pure Protein 28,396 255 28,651 Rest of World 9,268 246 9,514 $ 158,839 $ 40 $ 158,879 Corporate and Other (13,649 ) (880 ) (14,529 ) $ 145,190 $ (840 ) $ 144,350 (1) The information previously reported for the six months ended December 31, 2015 has been adjusted to reflect the Company’s new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment Information, for additional details surrounding the formation of Cultivate.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Numerator: Net income $ 27,185 $ 58,080 $ 35,789 $ 87,238 Denominator ( in thousands ): Basic earnings per share - weighted average shares outstanding during the period 103,597 103,017 103,532 102,912 Effect of dilutive stock options, unvested restricted stock and unvested restricted share units 607 1,144 693 1,297 Diluted earnings per share - adjusted weighted average shares and assumed conversions $ 104,204 $ 104,161 $ 104,225 $ 104,209 Net income per common share: Basic $ 0.26 $ 0.56 $ 0.35 $ 0.85 Diluted $ 0.26 $ 0.56 $ 0.34 $ 0.84 Basic earnings per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units. Diluted earnings per share includes the dilutive effects of common stock equivalents such as stock options and unvested restricted stock awards. There were 275 and 59 stock based awards excluded from our diluted earnings per share calculations for the three and six months ended December 31, 2016 and 2015 , respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Additionally, 27 restricted stock awards were excluded from our diluted earnings per share calculation for both the three and six months ended December 31, 2016 as such awards were antidilutive. There were no antidilutive awards excluded from our diluted earnings per share calculation for the three and six months ended December 31, 2015 .

Acquisitions

Acquisitions	6 Months Ended
	Dec. 31, 2016
Business Combinations [Abstract]
Acquisitions	ACQUISITIONS The Company accounts for acquisitions in accordance with ASC 805, Business Combinations . The results of operations of the acquisitions have been included in the consolidated results from their respective dates of acquisition. The purchase price of each acquisition is allocated to the tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. Acquisitions may include contingent consideration, the fair value of which is estimated on the acquisition date as the present value of the expected contingent payments, determined using weighted probabilities of possible payments. The fair values assigned to identifiable intangible assets acquired were determined primarily by using an income approach which was based on assumptions and estimates made by management. Significant assumptions utilized in the income approach were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by authoritative guidance. The excess of the purchase price over the fair value of the identified assets and liabilities has been recorded as goodwill. The costs related to all acquisitions have been expensed as incurred and are included in “Acquisition related expenses, restructuring and integration charges and other” in the Consolidated Statements of Income. Acquisition related expenses of $253 were expensed in the six months ended December 31, 2016 , and $1,948 and $2,961 were expensed in the three and six months ended December 31, 2015 , respectively. The Company did not incur any acquisition related expenses in the three months ended December 31, 2016 . The expenses incurred during the first six months of fiscal 2017 and 2016 primarily related to the acquisitions of Orchard House and Mona (as defined below). Fiscal 2016 On December 21, 2015, the Company acquired Orchard House Foods Limited (“Orchard House”), a leader in pre-cut fresh fruit, juices, fruit desserts and ingredients with facilities in Corby and Gateshead in the United Kingdom. Orchard House supplies leading retailers, on-the-go food outlets, food service providers and manufacturers in the United Kingdom. Consideration in the transaction consisted of cash (net of cash acquired) totaling £76,923 ( $114,113 at the transaction date exchange rate). The acquisition was funded with borrowings under the Credit Agreement (as defined in Note 9, Debt and Borrowings ). Additionally, contingent consideration of £3,000 was potentially payable to the sellers based on the outcome of a review by the Competition and Markets Authority in the United Kingdom. As a result of this review, the Company agreed to divest certain portions of its own-label juice business in the fourth quarter of fiscal 2016. On September 15, 2016, the contingent consideration obligation referenced above was settled in the amount of £1,500 (see Note 14, Financial Instruments Measured at Fair Value ). Orchard House is included in the United Kingdom operating segment. On July 24, 2015, the Company acquired Formatio Beratungs-und Beteiligungs GmbH and its subsidiaries (“Mona”), a leader in plant-based foods and beverages with facilities in Germany and Austria. Mona offers a wide range of organic and natural products under the Joya ® and Happy ® brands, including soy, oat, rice and nut based drinks as well as plant-based yogurts, desserts, creamers, tofu and private label products, sold to leading retailers in Europe, primarily in Austria and Germany and eastern European countries. Consideration in the transaction consisted of cash, net of cash acquired, totaling €22,753 ( $24,948 at the transaction date exchange rate) and 240 shares of the Company’s common stock valued at $16,308 . Also included in the acquisition was the assumption of net debt totaling €16,252 . The cash portion of the purchase price was funded with borrowings under our Credit Agreement. Mona is included in the Europe operating segment. The following table provides unaudited pro forma results of continuing operations for the three and six months ended December 31, 2015 , as if the acquisitions of Orchard House and Mona had been completed at the beginning of fiscal 2016. The information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the periods presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results. Three Months ended December 31, Six Months ended December 31, 2015 2015 Net sales $ 780,746 $ 1,501,551 Net income $ 57,721 $ 91,055 Net income per diluted common share $ 0.55 $ 0.87

Inventories

Inventories	6 Months Ended
	Dec. 31, 2016
Inventory, Net [Abstract]
Inventories	INVENTORIES Inventories consisted of the following: December 31, June 30, Finished goods $ 266,675 $ 238,184 Raw materials, work-in-progress and packaging 163,903 170,380 $ 430,578 $ 408,564

Property, Plant And Equipment,

Property, Plant And Equipment, Net	6 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property, Plant And Equipment, Net	PROPERTY, PLANT AND EQUIPMENT, NET Property, plant and equipment, net consisted of the following: December 31, June 30, Land $ 32,634 $ 35,825 Buildings and improvements 106,274 102,086 Machinery and equipment 346,388 358,362 Computer hardware and software 48,357 48,829 Furniture and fixtures 14,072 14,165 Leasehold improvements 27,800 28,471 Construction in progress 19,496 14,495 595,021 602,233 Less: Accumulated depreciation and amortization 222,939 212,392 $ 372,082 $ 389,841 Depreciation and amortization expense for the three months ended December 31, 2016 and 2015 was $9,888 and $9,286 , respectively. Such expense for the six months ended December 31, 2016 and 2015 was $20,116 and $18,389 , respectively.

Goodwill And Other Intangible A

Goodwill And Other Intangible Assets	6 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill And Other Intangible Assets	GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill The following table shows the changes in the carrying amount of goodwill by business segment: United States United Kingdom Hain Pure Protein Rest of World Total Balance as of June 30, 2016 (a): $ 605,702 $ 332,561 $ 41,089 $ 80,984 $ 1,060,336 Reallocation of goodwill between reporting units (16,377 ) — — 16,377 — Translation and other adjustments, net (2,431 ) (27,135 ) — (3,110 ) (32,676 ) Balance as of December 31, 2016 (a): $ 586,894 $ 305,426 $ 41,089 $ 94,251 $ 1,027,660 (a) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment. The Company performs its annual test for goodwill and indefinite lived intangible asset impairment as of the first day of the fourth quarter of its fiscal year. In addition, if and when events or circumstances change that would more likely than not reduce the fair value of any of its reporting units or indefinite-life intangible assets below their carrying value, an interim test is performed. During fiscal 2016, the Company recorded a goodwill impairment charge of $82,614 related to its Hain Daniels reporting unit in the United Kingdom. Additionally, a goodwill impairment charge of $1,934 was recognized during the fiscal year ended June 30, 2016 related to the divestiture of certain portions of the Company’s own-label juice business in connection with the Orchard House acquisition, which was sold in the first quarter of fiscal 2017. See Note 5, Acquisitions , for details. During the first quarter of fiscal 2017, changes in the Company’s internal management and reporting structure resulted in a change in operating segments. Certain brands previously included within the United States operating segment were moved to a new operating segment called Cultivate, which is now combined with Canada and Europe and reported within the “Rest of World” reportable segment. As such, goodwill was reallocated using a relative fair value allocation approach from the United States reportable segment to the Rest of World reportable segment. See Note 1, Business , and Note 16, Segment Information , for additional details surrounding Cultivate and the change in segments. This change in operating segments was deemed a triggering event, resulting in the Company performing an interim goodwill impairment analysis on the reporting units impacted by this segment change as of immediately before and immediately after the change. There were no impairment indicators resulting from this analysis, and there were no impairment charges recorded during the six months ended December 31, 2016. Other Intangible Assets The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization: December 31, June 30, Non-amortized intangible assets: Trademarks and tradenames (a) $ 423,815 $ 441,140 Amortized intangible assets: Other intangibles 231,253 245,040 Less: accumulated amortization (87,162 ) (81,393 ) Net carrying amount $ 567,906 $ 604,787 (a) The gross carrying value of trademarks and tradenames is reflected net of $46,123 of accumulated impairment charges. Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trade names and trademarks. Indefinite-lived intangible assets are evaluated on an annual basis, in conjunction with the Company’s evaluation of goodwill. In assessing fair value, the Company utilizes a “relief from royalty” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value in the period identified. The result of this assessment indicated that the fair value of certain of the Company’s tradenames was below their carrying value, and therefore an impairment charge of $39,724 ( $20,932 in the United Kingdom segment and $18,792 in the United States segment) was recognized during the fiscal year ended June 30, 2016. There were no other impairment charges recorded during fiscal 2016, and no impairment charges were recorded during the six months ended December 31, 2016. Amortizable intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and are being amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as follows: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Amortization of intangible assets $ 4,693 $ 4,704 $ 9,421 $ 9,343

Debt and Borrowings

Debt and Borrowings	6 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt and Borrowings	DEBT AND BORROWINGS Debt and borrowings consisted of the following: December 31, June 30, Credit Agreement borrowings payable to banks $ 783,911 $ 827,860 Tilda short-term borrowing arrangements 12,132 19,121 Other borrowings 7,017 15,703 803,060 862,684 Short-term borrowings and current portion of long-term debt 12,369 26,513 $ 790,691 $ 836,171 Credit Agreement On December 12, 2014, the Company entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) which provides for a $1,000,000 unsecured revolving credit facility which may be increased by an additional uncommitted $350,000 , provided certain conditions are met. The Credit Agreement expires in December 2019 . Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros, Pounds Sterling and Canadian Dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants usual and customary for facilities of its type, which include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants, such as maintaining a consolidated interest coverage ratio (as defined in the Credit Agreement) of no less than 4.0 to 1.0 and a consolidated leverage ratio (as defined in the Credit Agreement) of no more than 3.5 to 1.0 . The consolidated leverage ratio is subject to a step-up to 4.0 to 1.0 for the four full fiscal quarters following an acquisition. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of December 31, 2016 , there were $783,911 of borrowings and $6,180 letters of credit outstanding under the Credit Agreement and $209,909 available. The Company was deemed to be in compliance with all associated covenants due to certain limited waivers and extensions received by the Company in connection with its obligation to deliver financial information. The Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875% to 1.70% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 0.70% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Swing line loans and Global Swing Line loans denominated in U.S. dollars will bear interest at the Base Rate plus the Applicable Rate and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Credit Agreement at December 31, 2016 was 1.98% . Additionally, the Credit Agreement contains a Commitment Fee, as defined in the Credit Agreement, on the amount unused under the Credit Agreement ranging from 0.20% to 0.30% per annum. Such Commitment Fee is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Tilda Short-Term Borrowing Arrangements Tilda maintains short-term borrowing arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted under all such arrangements are £52,000 . Outstanding borrowings are collateralized by the current assets of Tilda, typically have six -month terms and bear interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate of approximately 2.8% at December 31, 2016 ). Other Borrowings Other borrowings primarily relate to a cash pool facility in Europe. The cash pool facility provides our Europe operating segment with sufficient liquidity to support the Company’s growth objectives within this segment. The maximum borrowings permitted under the cash pool arrangement are €12,500 . Outstanding borrowings bear interest at variable rates typically based on EURIBOR plus a margin of 1.1% (weighted average interest rate of approximately 1.1% at December 31, 2016 ).

Income Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES The Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements. The effective income tax rate from continuing operations was 27.9% and 28.0% for the three months ended December 31, 2016 and 2015 , respectively, and 24.1% and 29.2% for the six months ended December 31, 2016 and 2015 , respectively. The effective tax rate for the three and six months ended December 31, 2016 was favorably impacted by the geographical mix of earnings and a reduction in the statutory tax rate in the United Kingdom enacted in the first quarter of fiscal 2017. Such reduction resulted in a decrease to the carrying value of net deferred tax liabilities of $2,086 which favorably impacted the effective tax rate. The effective income tax rate for the three and six months ended December 31, 2015 was also favorably impacted by a reduction in the statutory tax rate in the United Kingdom enacted in the second quarter of fiscal 2016. This reduction in the statutory tax rate resulted in a $4,400 decrease to the carrying value of net deferred tax liabilities, which favorably impacted the effective tax rate, partially offset by an unfavorable $1,200 settlement of a tax claim in the United Kingdom relating to a prior acquisition.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Dec. 31, 2016
Stockholders' Equity Note [Abstract]
Accumulated Other Comprehensive Loss	ACCUMULATED OTHER COMPREHENSIVE LOSS The following tables present the changes in accumulated other comprehensive loss: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Foreign currency translation adjustments: Other comprehensive (loss) before reclassifications (1) $ (51,222 ) $ (25,655 ) $ (82,958 ) $ (65,587 ) Deferred gains/(losses) on cash flow hedging instruments: Other comprehensive income before reclassifications 45 1,118 101 3,271 Amounts reclassified into income (2) (55 ) (1,414 ) (506 ) (2,226 ) Unrealized gain/(loss) on available for sale investment: Other comprehensive income (loss) before reclassifications (19 ) 24 (69 ) (132 ) Amounts reclassified into income (3) — — 10 — Net change in accumulated other comprehensive loss $ (51,251 ) $ (25,927 ) $ (83,422 ) $ (64,674 ) (1) Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature of $12,908 and $16,076 for the three months ended December 31, 2016 and 2015 , respectively, and $20,061 and $41,811 for the six months ended December 31, 2016 and 2015 , respectively. (2) Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $530 and $1,862 for the three months ended December 31, 2016 and 2015 , respectively, and $1,150 and $2,946 for the six months ended December 31, 2016 and 2015 , respectively. (3) Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 13, Investments and Joint Ventures). Such amounts are recorded in “Other (income)/expense, net” in the Consolidated Statements of Income and were $16 before taxes for the six months ended December 31, 2016 .

Stock Based Compensation And In

Stock Based Compensation And Incentive Performance Plans	6 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Based Compensation And Incentive Performance Plans	STOCK BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS The Company has two shareholder-approved plans, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan and the 2000 Directors Stock Plan, under which the Company’s officers, senior management, other key employees, consultants and directors may be granted options to purchase the Company’s common stock or other forms of equity-based awards. Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Compensation cost (included in selling, general and administrative expense) $ 2,531 $ 4,023 $ 5,235 $ 7,229 Related income tax benefit $ 949 $ 1,499 $ 1,963 $ 2,710 Stock Options A summary of the stock option activity for the six months ended December 31, 2016 is as follows: Number of Options Weighted Average Exercise Price Weighted Average Contractual Life (years) Aggregate Intrinsic Value Options outstanding and exercisable at June 30, 2016 342 $ 6.66 Exercised (220 ) $ 9.10 Options outstanding and exercisable at December 31, 2016 122 $ 2.26 14.5 years $ 4,484 Six Months Ended December 31, 2016 2015 Intrinsic value of options exercised $ 6,507 $ — Tax benefit recognized from stock option exercises $ 2,538 $ — At December 31, 2016 , there was no unrecognized compensation expense related to stock option awards. Restricted Stock A summary of the restricted stock and restricted share units activity for the six months ended December 31, 2016 is as follows: Number of Shares and Units Weighted Average Grant Date Fair Value (per share) Non-vested restricted stock, restricted share units, and performance units at June 30, 2016 1,121 $ 28.24 Vested (267 ) $ 32.37 Forfeited (14 ) $ 33.14 Non-vested restricted stock, restricted share units, and performance units at December 31, 2016 840 $ 27.28 Six Months Ended December 31, 2016 2015 Fair value of restricted stock, restricted share units, and performance units granted $ — $ 9,660 Fair value of shares vested $ 9,004 $ 17,855 Tax benefit recognized from restricted shares vesting $ 3,464 $ 6,743 On July 3, 2012, the Company entered into a Restricted Stock Agreement (the “Agreement”) with Irwin D. Simon, the Company’s Chairman, President and Chief Executive Officer. The Agreement provides for a grant of 800 shares of restricted stock (the “Shares”), the vesting of which is both market and time-based. The market condition is satisfied in increments of 200 Shares upon the Company’s common stock achieving four share price targets. On the last day of any forty-five consecutive trading day period during which the average closing price of the Company’s common stock on the Nasdaq Global Select Market equals or exceeds the following prices: $31.25 , $36.25 , $41.25 and $50.00 , respectively, the market condition for each increment of 200 Shares will be satisfied. The market conditions must be satisfied prior to June 30, 2017. Once each market condition has been satisfied, a tranche of 200 Shares will vest in equal amounts annually over a five -year period. Except in the case of a change of control, termination without cause, death or disability (each as defined in Mr. Simon’s Employment Agreement), the unvested Shares are subject to forfeiture unless Mr. Simon remains employed through the applicable market and time vesting periods. The grant date fair value for each tranche was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment and the time frame most likely for goal attainment. The total grant date fair value of the Shares was estimated to be $16,151 , which was expected to be recognized over a weighted-average period of approximately 4.0 years . On September 28, 2012, August 27, 2013, December 13, 2013 and October 22, 2014, the four respective market conditions were satisfied. As such, the four tranches of 200 Shares are expected to vest in equal amounts over the five -year period commencing on the first anniversary of the date the market condition for the respective tranche was satisfied. At December 31, 2016 , $10,883 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested restricted stock awards, inclusive of the Shares, was expected to be recognized over a weighted-average period of approximately 1.3 years . Long-Term Incentive Plan The Company maintains a long-term incentive program (the “LTI Plan”). The LTI Plan currently consists of a two -year performance-based long-term incentive plan (the “2015-2016 LTIP”) and a three -year performance-based long-term incentive plan (the “2016-2018 LTIP”) that provide for a combination of equity grants and performance awards that can be earned over the respective performance period. Participants in the LTI Plan include the Company’s executive officers, including the Chief Executive Officer, and certain other key executives. The Compensation Committee administers the LTI Plan and is responsible for, among other items, establishing the target values of awards to participants and selecting the specific performance factors for such awards. The Compensation Committee determines the specific payout to the participants. Such awards may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, provided that any such stock-based awards shall be issued pursuant to and be subject to the terms and conditions of the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan, as in effect and as amended from time to time. Upon the adoption of the 2015-2016 LTIP, the Compensation Committee granted an initial award to each participant in the form of equity-based instruments (restricted stock or restricted share units), for a portion of the individual target awards (the “Initial Equity Grants”). These Initial Equity Grants are subject to time vesting requirements, and a portion are also subject to the achievement of minimum performance goals. The 2015-2016 LTIP awards contain an additional year of time-based vesting. The Initial Equity Grants are expensed over the respective vesting periods on a straight-line basis. The payment of the actual awards earned at the end of the applicable performance period, if any, will be reduced by the value of the Initial Equity Grants. Upon adoption of the 2016-2018 LTIP, the Compensation Committee granted performance units to each participant, the achievement of which is dependent upon a defined calculation of relative total shareholder return over the period from July 1, 2015 to June 30, 2018 (the “TSR Grant”). The grant date fair value for these awards was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment. Each performance unit translates into one unit of common stock. The TSR grant represents half of each participant’s target award. The other half of the 2016-2018 LTIP is based on the Company’s achievement of specified net sales growth targets over this three -year period and, if achieved, may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee. The Company has recorded expense (in addition to the stock based compensation expense associated with the Initial Equity Grants and the TSR Grant) of $1,128 and $2,255 for the three and six months ended December 31, 2016 , respectively, due to the Company’s current estimates of achievement under the plans. The Company recorded expense of $4,069 and $4,290 for the three and six months ended December 31, 2015 , respectively, related to the LTI Plan.

Investments And Joint Ventures

Investments And Joint Ventures	6 Months Ended
	Dec. 31, 2016
Equity Method Investments and Joint Ventures [Abstract]
Investments And Joint Ventures	INVESTMENTS AND JOINT VENTURES Equity method investments In October 2009, the Company formed a joint venture, Hutchison Hain Organic Holdings Limited (“HHO”), with Hutchison China Meditech Ltd. (“Chi-Med”), a majority-owned subsidiary of CK Hutchison Holdings Limited, to market and distribute certain of the Company’s brands in Hong Kong, China and other surrounding markets. Voting control of the joint venture is shared equally between the Company and Chi-Med, although, in the event of a deadlock, Chi-Med has the ability to cast the deciding vote, and therefore the investment is being accounted for under the equity method of accounting. At December 31, 2016 and June 30, 2016 , the carrying value of the Company’s 50.0% investment in and advances to HHO were $948 and $1,729 , respectively, and are included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” On October 27, 2015, the Company acquired a 14.9% interest in Chop’t Creative Salad Company LLC (“Chop’t”). Chop’t develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. Chop’t markets and sells certain of the Company’s branded products and provides consumer insight and feedback. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors. At December 31, 2016 and June 30, 2016 , the carrying value of the Company’s investment in Chop’t was $17,222 and $17,448 , respectively, and is included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” The Company’s current ownership percentage may be diluted in the future to 12.1% , pending the distribution of additional ownership interests. Available-For-Sale Securities The Company has a less than 1% equity ownership interest in Yeo Hiap Seng Limited (“YHS”), a Singapore-based natural food and beverage company listed on the Singapore Exchange, which is accounted for as an available-for-sale security. The Company sold 81 of its YHS shares during the six months ended December 31, 2016 which resulted in a pre-tax loss of $16 on the sales, and recognized as a component of “Other (income)/expense, net.” No shares were sold during the six months ended December 31, 2015 . The remaining shares held at December 31, 2016 totaled 955 . The fair value of these shares held was $877 (cost basis of $1,190 ) at December 31, 2016 and $1,067 (cost basis of $1,291 ) at June 30, 2016 and is included in “Investments and joint ventures,” with the related unrealized gain or loss, net of tax, included in “Accumulated other comprehensive loss” in the Consolidated Balance Sheet. The company concluded that the decline in its YHS investment below its cost basis is temporary and, accordingly, has not recognized a loss in the Consolidated Statements of Operations. In making this determination, the company considered its intent and ability to hold the investment until the cost is recovered, the financial condition and near-term prospects of YHS, the magnitude of the loss compared to the investment’s cost, and publicly available information about the industry and geographic region in which YHS operates.

Financial Instruments Measured

Financial Instruments Measured At Fair Value	6 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Financial Instruments Measured At Fair Value	FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are: • Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; • Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and • Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of December 31, 2016 : Total Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Assets: Cash equivalents $ 47,609 $ 47,609 $ — $ — Forward foreign currency contracts 52 — 52 — Available for sale securities 877 877 — — $ 48,538 $ 48,486 $ 52 $ — Liabilities: Contingent consideration, current $ 1,702 $ — $ — $ 1,702 Total $ 1,702 $ — $ — $ 1,702 The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2016 : Total Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Assets: Cash equivalents $ 20,706 $ 20,706 $ — $ — Forward foreign currency contracts 531 — 531 — Available for sale securities 1,067 1,067 — — $ 22,304 $ 21,773 $ 531 $ — Liabilities: Contingent consideration, current $ 3,553 $ — $ — $ 3,553 Total $ 3,553 $ — $ — $ 3,553 Available for sale securities consist of the Company’s investment in YHS (see Note 13, Investments and Joint Ventures ). Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices. The Company estimates the original fair value of the contingent consideration as the present value of the expected contingent payments, determined using the weighted probabilities of the possible payments. The Company reassesses the fair value of contingent payments on a periodic basis. Although the Company believes that its estimated and assumptions are reasonable, different assumptions, including those regarding the operating results of the respective businesses, or changes in the future may result in different estimated amounts. At December 31, 2016 , contingent consideration of $1,702 was included in “Accrued expenses and other current liabilities” in the Company’s Consolidated Balance Sheet in connection with the acquisition of Belvedere International, Inc. in February 2015. The following table summarizes the Level 3 activity for the six months ended December 31, 2016 . Balance as of June 30, 2016 $ 3,553 Contingent consideration adjustment and accretion of interest expense, net 526 Contingent consideration paid (a) (2,498 ) Translation adjustment 121 Balance as of December 31, 2016 $ 1,702 (a) Contingent consideration payment relates to the acquisition of Orchard House completed in December 2015. See Note 5, Acquisitions. There were no transfers of financial instruments between the three levels of fair value hierarchy during the six months ended December 31, 2016 or 2015 . The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (See Note 9, Debt and Borrowings ). Derivative Instruments The Company primarily has exposure to changes in foreign currency exchange rates relating to certain anticipated cash flows from its international operations. To reduce that risk, the Company may enter into certain derivative financial instruments, when available on a cost-effective basis, to manage such risk. Derivative financial instruments are not used for speculative purposes. The Company utilizes foreign currency contracts to hedge forecasted transactions, including intercompany transactions, on certain foreign currencies and designates these derivative instruments as foreign currency cash flow hedges when appropriate. The Company also occasionally enters into fair value hedges to mitigate its foreign currency risk related to certain firm commitments. The notional and fair value amounts of the Company’s foreign exchange derivative contracts outstanding at December 31, 2016 were $3,155 and $52 of net assets, respectively. There were $6,000 of notional amount and $531 of net assets of foreign exchange derivative contracts outstanding at June 30, 2016 . The fair value of these derivatives is included in prepaid expenses and other current assets and accrued expenses and other current liabilities in the Consolidated Balance Sheet. For these derivatives, which qualify as hedges of probable forecasted cash flows, the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive income and recognized in earnings when the hedged item affects earnings. These foreign exchange contracts have maturities over the next six months . The Company assesses effectiveness at the inception of the hedge and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of change in fair value is not deferred in accumulated other comprehensive income and is included in current period results. For the three and six months ended December 31, 2016 and 2015 , the impact of hedge ineffectiveness on earnings was not significant. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date or when the hedge is no longer effective. There were no discontinued foreign exchange hedges for the three and six months ended December 31, 2016 and 2015 .

Commitments And Contingencies

Commitments And Contingencies	6 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	COMMITMENTS AND CONTINGENCIES Securities Class Actions Filed in Federal Court On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al. , (the “Flora Complaint”); (2) Lynn v. the Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). The Securities Complaints allege that the Company and certain of its officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The Securities Complaints were brought on behalf of all persons who purchased or otherwise acquired Hain securities between November 5, 2015 and August 15, 2016. On October 17, 2016, six potential plaintiffs and their respective law firms moved to serve as lead plaintiff and counsel. On June 5, 2017, the Court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation , and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. Stockholder Derivative Complaints Filed in State Court On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”) , was filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively. Both the Scarola Complaint and the Shakir Complaint allege breach of fiduciary duty, lack of oversight and unjust enrichment. On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau County, and the parties agreed to stay the Consolidated Derivative Action until November 2, 2017. Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment. On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of Directors and certain officers of the Company. The complaint alleges that the Company’s directors and certain officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleges that the Company violated its by-laws and Delaware law by failing to hold an Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. SEC Investigation As previously disclosed, the Company voluntarily contacted the SEC in August 2016 to advise it of the Company’s delay in the filing of its periodic reports and the performance of the independent review conducted by the Audit Committee. The Company has continued to provide information to the SEC on an ongoing basis, including, among other things, the results of the independent review of the Audit Committee as well as other information pertaining to its internal accounting review relating to revenue recognition. On January 31, 2017, the SEC issued a subpoena to the Company seeking documents relevant to its investigation. The Company is in the process of responding to the SEC’s requests for information and intends to cooperate fully with the SEC. Other In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.

Segment Information

Segment Information	6 Months Ended
	Dec. 31, 2016
Segment Reporting [Abstract]
Segment Information	SEGMENT INFORMATION Prior to July 1, 2016, the Company’s operations were managed in seven operating segments: the United States, United Kingdom, Tilda, Hain Pure Protein Corporation (“HPPC”), EK Holdings, Inc. (“Empire”), Canada and Europe. The United States operating segment was also a reportable segment. The United Kingdom and Tilda operating segments were reported in the aggregate as “United Kingdom”, while HPPC and Empire were reported in the aggregate as “Hain Pure Protein,” and Canada and Europe were combined and reported as “Rest of World.” Effective July 1, 2016, due to changes to the Company’s internal management and reporting structure resulting from the formation of Cultivate, certain brands previously included within the United States operating segment were moved to a new operating segment called Cultivate. As a result, the Company is now managed in eight operating segments: the United States (excluding Cultivate), United Kingdom, Tilda, HPPC, Empire, Canada, Europe and Cultivate. The United States, excluding Cultivate, is its own reportable segment. Cultivate is now combined with Canada and Europe and reported within the “Rest of World” reportable segment. There were no changes to the United Kingdom and Hain Pure Protein reportable segments. The prior period segment information contained below has been adjusted to reflect the Company’s new operating and reporting structure. See Note 1, Business , for additional details surrounding the formation of Cultivate. Net sales and operating income are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in “Corporate and Other.” Corporate and Other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Additionally, acquisition related expenses, restructuring and integration charges and other, along with accounting review costs are included in “Corporate and Other.” Expenses that are managed centrally but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Assets are reviewed by the CODM on a consolidated basis and therefore are not reported by operating segment. The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented. Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Net Sales: United States $ 298,127 $ 314,685 $ 573,734 $ 617,316 United Kingdom 192,825 191,254 391,601 352,109 Hain Pure Protein 152,979 144,192 269,648 267,247 Rest of World 96,068 93,306 186,480 174,492 $ 739,999 $ 743,437 $ 1,421,463 $ 1,411,164 Operating Income: United States $ 42,552 $ 50,940 $ 64,615 $ 92,447 United Kingdom 6,697 18,425 11,247 28,267 Hain Pure Protein 3,541 18,162 2,523 28,651 Rest of World 7,477 7,091 12,532 9,514 $ 60,267 $ 94,618 $ 90,917 $ 158,879 Corporate and Other (1) (18,867 ) (4,540 ) (35,766 ) (14,529 ) $ 41,400 $ 90,078 $ 55,151 $ 144,350 (1) Includes $7,113 and $2,498 of accounting review costs and acquisition related expenses, restructuring and integration charges and other for the three months ended December 31, 2016 and 2015 , respectively. Such expenses for the six months ended December 31, 2016 and 2015 were $13,534 and $4,591 , respectively. The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic area are as follows: December 31, June 30, United States $ 196,522 $ 193,192 United Kingdom 174,460 196,271 All Other 52,005 53,260 $ 422,987 $ 442,723 The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) United States $ 446,412 $ 457,882 $ 832,180 $ 878,512 United Kingdom 212,312 211,380 432,463 393,531 All Other 81,275 74,175 156,820 139,121 Total $ 739,999 $ 743,437 $ 1,421,463 $ 1,411,164

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements Not Yet Effective	Recently Issued Accounting Pronouncements Not Yet Effective Summary of Significant Accounting Policies and Practices , in the Notes to the Consolidated Financial Statements as of June 30, 2016 and for the fiscal year then ended included in the Form 10-K for a detailed discussion on recently issued accounting pronouncements not yet adopted by the Company. There has been no change to the statements made in the Form 10-K as of the date of filing of this Form 10-Q.

Correction of Immaterial Erro26

Correction of Immaterial Errors To Prior Period Financial Statements (Tables)	6 Months Ended
	Dec. 31, 2016
Accounting Changes and Error Corrections [Abstract]
Schedule of Correction of Immaterial Errors to Prior Period Financial Statements	CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Three Months Ended December 31, 2015 As Reported Adjustment As Revised Net sales $ 752,589 $ (9,152 ) $ 743,437 Cost of sales 575,026 2,150 577,176 Gross profit 177,563 (11,302 ) 166,261 Selling, general and administrative expenses 82,607 (13,626 ) 68,981 Amortization of acquired intangibles 4,736 (32 ) 4,704 Acquisition related expenses, restructuring and integration charges and other 2,498 — 2,498 Operating income 87,722 2,356 90,078 Interest and other financing expense, net 6,300 — 6,300 Other (income)/expense, net 3,065 — 3,065 Income before income taxes and equity in earnings of equity- method investees 78,357 2,356 80,713 Provision for income taxes 21,379 1,223 22,602 Equity in net loss of equity-method investees 31 — 31 Net income $ 56,947 $ 1,133 $ 58,080 Net income per common share: Basic $ 0.55 $ 0.01 $ 0.56 Diluted $ 0.55 $ 0.01 $ 0.56 Weighted average common shares outstanding: Basic 103,017 103,017 103,017 Diluted 104,161 104,161 104,161 * Net income per common share may not add in certain periods due to rounding Six Months Ended December 31, 2015 As Reported Adjustment As Revised Net sales $ 1,439,777 $ (28,613 ) $ 1,411,164 Cost of sales 1,110,167 (3,145 ) 1,107,022 Gross profit 329,610 (25,468 ) 304,142 Selling, general and administrative expenses 168,861 (24,330 ) 144,531 Amortization/impairment of acquired intangibles 9,408 (65 ) 9,343 Acquisition related expenses, restructuring and integration charges and other 6,151 (233 ) 5,918 Operating income 145,190 (840 ) 144,350 Interest and other financing expense, net 12,767 — 12,767 Other (income)/expense, net 8,466 — 8,466 Income before income taxes and equity in earnings of equity- method investees 123,957 (840 ) 123,117 Provision for income taxes 35,761 171 35,932 Equity in net income of equity-method investees (53 ) — (53 ) Net income $ 88,249 $ (1,011 ) $ 87,238 Net income per common share: Basic $ 0.86 $ (0.01 ) $ 0.85 Diluted $ 0.85 $ (0.01 ) $ 0.84 Weighted average common shares outstanding: Basic 102,912 102,912 102,912 Diluted 104,209 104,209 104,209 * Net income per common share may not add in certain periods due to rounding CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Three Months Ended December 31, 2015 Six Months Ended December 31, 2015 As Reported Adjustment As Revised As Reported Adjustment As Revised Net income $ 56,947 $ 1,133 $ 58,080 $ 88,249 $ (1,011 ) $ 87,238 Other comprehensive income (loss): Foreign currency translation adjustments $ (25,791 ) $ 136 (25,655 ) $ (66,084 ) 497 (65,587 ) Change in deferred gains (losses) on cash flow hedging instruments (296 ) — (296 ) 1,045 — 1,045 Change in unrealized gain (loss) on available for sale investment 24 — 24 (132 ) — (132 ) Total other comprehensive income (loss) $ (26,063 ) $ 136 $ (25,927 ) $ (65,171 ) $ 497 $ (64,674 ) Total comprehensive income $ 30,884 $ 1,269 $ 32,153 $ 23,078 $ (514 ) $ 22,564 CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Six Months Ended December 31, 2015 As Reported Adjustment As Revised CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 88,249 $ (1,011 ) $ 87,238 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 31,409 381 31,790 Deferred income taxes (8,693 ) (155 ) (8,848 ) Equity in net income of equity-method investees (53 ) — (53 ) Stock based compensation 7,229 — 7,229 Other non-cash items, including unrealized currency (gains)/loss, net 7,812 — 7,812 Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions: Accounts receivable (17,231 ) (1,181 ) (18,412 ) Inventories (20,891 ) 2,598 (18,293 ) Other current assets 5,336 20,811 26,147 Other assets and liabilities 2,187 — 2,187 Accounts payable and accrued expenses 4,290 (21,443 ) (17,153 ) Net cash provided by operating activities $ 99,644 $ — $ 99,644 SEGMENT NET SALES AND OPERATING INCOME (UNAUDITED) Three Months Ended December 31, 2015 As Reported (1) Adjustment As Revised Net Sales: United States $ 322,878 $ (8,193 ) $ 314,685 United Kingdom 194,226 (2,972 ) 191,254 Hain Pure Protein 141,706 2,486 144,192 Rest of World 93,779 (473 ) 93,306 $ 752,589 $ (9,152 ) $ 743,437 Operating Income: United States $ 48,315 $ 2,625 $ 50,940 United Kingdom 18,768 (343 ) 18,425 Hain Pure Protein 18,125 37 18,162 Rest of World 6,595 496 7,091 $ 91,803 $ 2,815 $ 94,618 Corporate and Other (4,081 ) (459 ) (4,540 ) $ 87,722 $ 2,356 $ 90,078 (1) The information previously reported for the three months ended December 31, 2015 has been adjusted to reflect the Company’s new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment Information, for additional details surrounding the formation of Cultivate. Six Months Ended December 31, 2015 As Reported (1) Adjustment As Revised Net Sales: United States $ 637,464 $ (20,148 ) $ 617,316 United Kingdom 359,580 (7,471 ) 352,109 Hain Pure Protein 265,694 1,553 267,247 Rest of World 177,039 (2,547 ) 174,492 $ 1,439,777 $ (28,613 ) $ 1,411,164 Operating Income: United States $ 92,203 $ 244 $ 92,447 United Kingdom 28,972 (705 ) 28,267 Hain Pure Protein 28,396 255 28,651 Rest of World 9,268 246 9,514 $ 158,839 $ 40 $ 158,879 Corporate and Other (13,649 ) (880 ) (14,529 ) $ 145,190 $ (840 ) $ 144,350 (1) The information previously reported for the six months ended December 31, 2015 has been adjusted to reflect the Company’s new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment Information, for additional details surrounding the formation of Cultivate.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Computation Of Basic And Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Numerator: Net income $ 27,185 $ 58,080 $ 35,789 $ 87,238 Denominator ( in thousands ): Basic earnings per share - weighted average shares outstanding during the period 103,597 103,017 103,532 102,912 Effect of dilutive stock options, unvested restricted stock and unvested restricted share units 607 1,144 693 1,297 Diluted earnings per share - adjusted weighted average shares and assumed conversions $ 104,204 $ 104,161 $ 104,225 $ 104,209 Net income per common share: Basic $ 0.26 $ 0.56 $ 0.35 $ 0.85 Diluted $ 0.26 $ 0.56 $ 0.34 $ 0.84

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
	Dec. 31, 2016
Business Combinations [Abstract]
Summary of Unaudited Pro Forma Results of Continuing Operations	The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results. Three Months ended December 31, Six Months ended December 31, 2015 2015 Net sales $ 780,746 $ 1,501,551 Net income $ 57,721 $ 91,055 Net income per diluted common share $ 0.55 $ 0.87

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Dec. 31, 2016
Inventory, Net [Abstract]
Components Of Inventories	Inventories consisted of the following: December 31, June 30, Finished goods $ 266,675 $ 238,184 Raw materials, work-in-progress and packaging 163,903 170,380 $ 430,578 $ 408,564

Property, Plant And Equipment30

Property, Plant And Equipment, Net (Tables)	6 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment, Net	Property, plant and equipment, net consisted of the following: December 31, June 30, Land $ 32,634 $ 35,825 Buildings and improvements 106,274 102,086 Machinery and equipment 346,388 358,362 Computer hardware and software 48,357 48,829 Furniture and fixtures 14,072 14,165 Leasehold improvements 27,800 28,471 Construction in progress 19,496 14,495 595,021 602,233 Less: Accumulated depreciation and amortization 222,939 212,392 $ 372,082 $ 389,841

Goodwill And Other Intangible31

Goodwill And Other Intangible Assets (Tables)	6 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Changes In Carrying Amount Of Goodwill	The following table shows the changes in the carrying amount of goodwill by business segment: United States United Kingdom Hain Pure Protein Rest of World Total Balance as of June 30, 2016 (a): $ 605,702 $ 332,561 $ 41,089 $ 80,984 $ 1,060,336 Reallocation of goodwill between reporting units (16,377 ) — — 16,377 — Translation and other adjustments, net (2,431 ) (27,135 ) — (3,110 ) (32,676 ) Balance as of December 31, 2016 (a): $ 586,894 $ 305,426 $ 41,089 $ 94,251 $ 1,027,660 (a) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.
Components Of Trademarks And Other Intangible Assets	The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization: December 31, June 30, Non-amortized intangible assets: Trademarks and tradenames (a) $ 423,815 $ 441,140 Amortized intangible assets: Other intangibles 231,253 245,040 Less: accumulated amortization (87,162 ) (81,393 ) Net carrying amount $ 567,906 $ 604,787 (a) The gross carrying value of trademarks and tradenames is reflected net of $46,123 of accumulated impairment charges.
Schedule of Amortization Expense	Amortization expense included in continuing operations was as follows: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Amortization of intangible assets $ 4,693 $ 4,704 $ 9,421 $ 9,343

Debt and Borrowings (Tables)

Debt and Borrowings (Tables)	6 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Summary of Debt and Borrowings	Debt and borrowings consisted of the following: December 31, June 30, Credit Agreement borrowings payable to banks $ 783,911 $ 827,860 Tilda short-term borrowing arrangements 12,132 19,121 Other borrowings 7,017 15,703 803,060 862,684 Short-term borrowings and current portion of long-term debt 12,369 26,513 $ 790,691 $ 836,171

Accumulated Other Comprehensi33

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Dec. 31, 2016
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The following tables present the changes in accumulated other comprehensive loss: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Foreign currency translation adjustments: Other comprehensive (loss) before reclassifications (1) $ (51,222 ) $ (25,655 ) $ (82,958 ) $ (65,587 ) Deferred gains/(losses) on cash flow hedging instruments: Other comprehensive income before reclassifications 45 1,118 101 3,271 Amounts reclassified into income (2) (55 ) (1,414 ) (506 ) (2,226 ) Unrealized gain/(loss) on available for sale investment: Other comprehensive income (loss) before reclassifications (19 ) 24 (69 ) (132 ) Amounts reclassified into income (3) — — 10 — Net change in accumulated other comprehensive loss $ (51,251 ) $ (25,927 ) $ (83,422 ) $ (64,674 ) (1) Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature of $12,908 and $16,076 for the three months ended December 31, 2016 and 2015 , respectively, and $20,061 and $41,811 for the six months ended December 31, 2016 and 2015 , respectively. (2) Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $530 and $1,862 for the three months ended December 31, 2016 and 2015 , respectively, and $1,150 and $2,946 for the six months ended December 31, 2016 and 2015 , respectively. (3) Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 13, Investments and Joint Ventures). Such amounts are recorded in “Other (income)/expense, net” in the Consolidated Statements of Income and were $16 before taxes for the six months ended December 31, 2016 .

Stock Based Compensation And 34

Stock Based Compensation And Incentive Performance Plans (Tables)	6 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Compensation Cost And Related Income Tax Benefits Recognized	Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Compensation cost (included in selling, general and administrative expense) $ 2,531 $ 4,023 $ 5,235 $ 7,229 Related income tax benefit $ 949 $ 1,499 $ 1,963 $ 2,710
Summary Of Stock Option Activity	A summary of the stock option activity for the six months ended December 31, 2016 is as follows: Number of Options Weighted Average Exercise Price Weighted Average Contractual Life (years) Aggregate Intrinsic Value Options outstanding and exercisable at June 30, 2016 342 $ 6.66 Exercised (220 ) $ 9.10 Options outstanding and exercisable at December 31, 2016 122 $ 2.26 14.5 years $ 4,484
Schedule of Tax Benefits Recognized from Stock Options Exercises	Six Months Ended December 31, 2016 2015 Intrinsic value of options exercised $ 6,507 $ — Tax benefit recognized from stock option exercises $ 2,538 $ —
Non-Vested Restricted Stock And Restricted Share Unit Awards	A summary of the restricted stock and restricted share units activity for the six months ended December 31, 2016 is as follows: Number of Shares and Units Weighted Average Grant Date Fair Value (per share) Non-vested restricted stock, restricted share units, and performance units at June 30, 2016 1,121 $ 28.24 Vested (267 ) $ 32.37 Forfeited (14 ) $ 33.14 Non-vested restricted stock, restricted share units, and performance units at December 31, 2016 840 $ 27.28
Restricted Stock Grant Information	Six Months Ended December 31, 2016 2015 Fair value of restricted stock, restricted share units, and performance units granted $ — $ 9,660 Fair value of shares vested $ 9,004 $ 17,855 Tax benefit recognized from restricted shares vesting $ 3,464 $ 6,743

Financial Instruments Measure35

Financial Instruments Measured At Fair Value (Tables)	6 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Assets And Liabilities Measured At Fair Value On A Recurring Basis	The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of December 31, 2016 : Total Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Assets: Cash equivalents $ 47,609 $ 47,609 $ — $ — Forward foreign currency contracts 52 — 52 — Available for sale securities 877 877 — — $ 48,538 $ 48,486 $ 52 $ — Liabilities: Contingent consideration, current $ 1,702 $ — $ — $ 1,702 Total $ 1,702 $ — $ — $ 1,702 The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2016 : Total Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Assets: Cash equivalents $ 20,706 $ 20,706 $ — $ — Forward foreign currency contracts 531 — 531 — Available for sale securities 1,067 1,067 — — $ 22,304 $ 21,773 $ 531 $ — Liabilities: Contingent consideration, current $ 3,553 $ — $ — $ 3,553 Total $ 3,553 $ — $ — $ 3,553
Level 3 Activity	The following table summarizes the Level 3 activity for the six months ended December 31, 2016 . Balance as of June 30, 2016 $ 3,553 Contingent consideration adjustment and accretion of interest expense, net 526 Contingent consideration paid (a) (2,498 ) Translation adjustment 121 Balance as of December 31, 2016 $ 1,702 (a) Contingent consideration payment relates to the acquisition of Orchard House completed in December 2015. See Note 5, Acquisitions.

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Dec. 31, 2016
Segment Reporting [Abstract]
Schedule of Segment Reporting	The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented. Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) Net Sales: United States $ 298,127 $ 314,685 $ 573,734 $ 617,316 United Kingdom 192,825 191,254 391,601 352,109 Hain Pure Protein 152,979 144,192 269,648 267,247 Rest of World 96,068 93,306 186,480 174,492 $ 739,999 $ 743,437 $ 1,421,463 $ 1,411,164 Operating Income: United States $ 42,552 $ 50,940 $ 64,615 $ 92,447 United Kingdom 6,697 18,425 11,247 28,267 Hain Pure Protein 3,541 18,162 2,523 28,651 Rest of World 7,477 7,091 12,532 9,514 $ 60,267 $ 94,618 $ 90,917 $ 158,879 Corporate and Other (1) (18,867 ) (4,540 ) (35,766 ) (14,529 ) $ 41,400 $ 90,078 $ 55,151 $ 144,350 (1) Includes $7,113 and $2,498 of accounting review costs and acquisition related expenses, restructuring and integration charges and other for the three months ended December 31, 2016 and 2015 , respectively. Such expenses for the six months ended December 31, 2016 and 2015 were $13,534 and $4,591 , respectively.
Schedule of Disclosure on Geographic Areas	The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic area are as follows: December 31, June 30, United States $ 196,522 $ 193,192 United Kingdom 174,460 196,271 All Other 52,005 53,260 $ 422,987 $ 442,723
Schedule of Net Sales by Geographic Areas	The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows: Three Months Ended December 31, Six Months Ended December 31, 2016 2015 (As Revised) 2016 2015 (As Revised) United States $ 446,412 $ 457,882 $ 832,180 $ 878,512 United Kingdom 212,312 211,380 432,463 393,531 All Other 81,275 74,175 156,820 139,121 Total $ 739,999 $ 743,437 $ 1,421,463 $ 1,411,164

Business (Details)

Business (Details)	Dec. 31, 2016country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which entity operates (more than)	80

Correction of Immaterial Erro38

Correction of Immaterial Errors To Prior Period Financial Statements - Consolidated Statements of Income (Unaudited) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 739,999	$ 743,437	$ 1,421,463	$ 1,411,164
Cost of sales	601,606	577,176	1,173,203	1,107,022
Gross profit	138,393	166,261	248,260	304,142
Selling, general and administrative expenses	85,187	68,981	170,154	144,531
Amortization of acquired intangibles	4,693	4,704	9,421	9,343
Acquisition related expenses, restructuring and integration charges and other	108	2,498	568	5,918
Operating income	41,400	90,078	55,151	144,350
Interest and other financing expense, net	5,097	6,300	10,178	12,767
Other (income)/expense, net	(1,353)	3,065	(1,865)	8,466
Income before income taxes and equity in net (income) loss of equity-method investees	37,656	80,713	46,838	123,117
Provision for income taxes	10,509	22,602	11,271	35,932
Equity in net (income) loss of equity-method investees	(38)	31	(222)	(53)
Net income	$ 27,185	$ 58,080	$ 35,789	$ 87,238
Net income per common share:
Basic (USD per share)	$ 0.26	$ 0.56	$ 0.35	$ 0.85
Diluted (USD per share)	$ 0.26	$ 0.56	$ 0.34	$ 0.84
Weighted average common shares outstanding:
Basic (shares)	103,597	103,017	103,532	102,912
Diluted (shares)	104,204	104,161	104,225	104,209
As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		$ 752,589		$ 1,439,777
Cost of sales		575,026		1,110,167
Gross profit		177,563		329,610
Selling, general and administrative expenses		82,607		168,861
Amortization of acquired intangibles		4,736		9,408
Acquisition related expenses, restructuring and integration charges and other		2,498		6,151
Operating income		87,722		145,190
Interest and other financing expense, net		6,300		12,767
Other (income)/expense, net		3,065		8,466
Income before income taxes and equity in net (income) loss of equity-method investees		78,357		123,957
Provision for income taxes		21,379		35,761
Equity in net (income) loss of equity-method investees		31		(53)
Net income		$ 56,947		$ 88,249
Net income per common share:
Basic (USD per share)		$ 0.55		$ 0.86
Diluted (USD per share)		$ 0.55		$ 0.85
Weighted average common shares outstanding:
Basic (shares)		103,017		102,912
Diluted (shares)		104,161		104,209
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		$ (9,152)		$ (28,613)
Cost of sales		2,150		(3,145)
Gross profit		(11,302)		(25,468)
Selling, general and administrative expenses		(13,626)		(24,330)
Amortization of acquired intangibles		(32)		(65)
Acquisition related expenses, restructuring and integration charges and other		0		(233)
Operating income		2,356		(840)
Interest and other financing expense, net		0		0
Other (income)/expense, net		0		0
Income before income taxes and equity in net (income) loss of equity-method investees		2,356		(840)
Provision for income taxes		1,223		171
Equity in net (income) loss of equity-method investees		0		0
Net income		$ 1,133		$ (1,011)
Net income per common share:
Basic (USD per share)		$ 0.01		$ (0.01)
Diluted (USD per share)		$ 0.01		$ (0.01)
Weighted average common shares outstanding:
Basic (shares)		103,017		102,912
Diluted (shares)		104,161		104,209

Correction of Immaterial Erro39

Correction of Immaterial Errors To Prior Period Financial Statements - Consolidated Statements of Comprehensive Income (Unaudited) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income	$ 27,185	$ 58,080	$ 35,789	$ 87,238
Other comprehensive income (loss):
Foreign currency translation adjustments	(51,222)	(25,655)	(82,958)	(65,587)
Change in deferred gains (losses) on cash flow hedging instruments	(10)	(296)	(405)	1,045
Change in unrealized gain (loss) on available for sale investment	(19)	24	(59)	(132)
Net change in accumulated other comprehensive loss	(51,251)	(25,927)	(83,422)	(64,674)
Total comprehensive (loss) income	$ (24,066)	32,153	$ (47,633)	22,564
As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income		56,947		88,249
Other comprehensive income (loss):
Foreign currency translation adjustments		(25,791)		(66,084)
Change in deferred gains (losses) on cash flow hedging instruments		(296)		1,045
Change in unrealized gain (loss) on available for sale investment		24		(132)
Net change in accumulated other comprehensive loss		(26,063)		(65,171)
Total comprehensive (loss) income		30,884		23,078
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income		1,133		(1,011)
Other comprehensive income (loss):
Foreign currency translation adjustments		136		497
Change in deferred gains (losses) on cash flow hedging instruments		0		0
Change in unrealized gain (loss) on available for sale investment		0		0
Net change in accumulated other comprehensive loss		136		497
Total comprehensive (loss) income		$ 1,269		$ (514)

Correction of Immaterial Erro40

Correction of Immaterial Errors To Prior Period Financial Statements - Consolidated Statements of Cash Flows (Unaudited) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income			$ 35,789	$ 87,238
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			34,168	31,790
Deferred income taxes			(5,300)	(8,848)
Equity in net (income) loss of equity-method investees	$ (38)	$ 31	(222)	(53)
Stock based compensation			5,235	7,229
Other non-cash items including unrealized foreign currency (gains)/losses, net			(3,184)	7,812
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable			15,885	(18,412)
Inventories			(31,921)	(18,293)
Other current assets			20,854	26,147
Other assets and liabilities			(1,038)	2,187
Accounts payable and accrued expenses			42,547	(17,153)
Net cash provided by operating activities			$ 112,813	99,644
As Reported [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income				88,249
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization				31,409
Deferred income taxes				(8,693)
Equity in net (income) loss of equity-method investees		31		(53)
Stock based compensation				7,229
Other non-cash items including unrealized foreign currency (gains)/losses, net				7,812
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable				(17,231)
Inventories				(20,891)
Other current assets				5,336
Other assets and liabilities				2,187
Accounts payable and accrued expenses				4,290
Net cash provided by operating activities				99,644
Adjustment [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income				(1,011)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization				381
Deferred income taxes				(155)
Equity in net (income) loss of equity-method investees		$ 0		0
Stock based compensation				0
Other non-cash items including unrealized foreign currency (gains)/losses, net				0
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable				(1,181)
Inventories				2,598
Other current assets				20,811
Other assets and liabilities				0
Accounts payable and accrued expenses				(21,443)
Net cash provided by operating activities				$ 0

Correction of Immaterial Erro41

Correction of Immaterial Errors To Prior Period Financial Statements - Segment Net Sales and Operating Income (Unaudited) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 739,999	$ 743,437	$ 1,421,463	$ 1,411,164
Operating Income	41,400	90,078	55,151	144,350
As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		752,589		1,439,777
Operating Income		87,722		145,190
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		(9,152)		(28,613)
Operating Income		2,356		(840)
Operating Segments [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		743,437		1,411,164
Operating Income	60,267	94,618	90,917	158,879
Operating Segments [Member] | As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		752,589		1,439,777
Operating Income		91,803		158,839
Operating Segments [Member] | Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		(9,152)		(28,613)
Operating Income		2,815		40
Operating Segments [Member] | United States [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		314,685		617,316
Operating Income	42,552	50,940	64,615	92,447
Operating Segments [Member] | United States [Member] | As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		322,878		637,464
Operating Income		48,315		92,203
Operating Segments [Member] | United States [Member] | Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		(8,193)		(20,148)
Operating Income		2,625		244
Operating Segments [Member] | United Kingdom [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		191,254		352,109
Operating Income	6,697	18,425	11,247	28,267
Operating Segments [Member] | United Kingdom [Member] | As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		194,226		359,580
Operating Income		18,768		28,972
Operating Segments [Member] | United Kingdom [Member] | Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		(2,972)		(7,471)
Operating Income		(343)		(705)
Operating Segments [Member] | Hain Pure Protein [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		144,192		267,247
Operating Income	3,541	18,162	2,523	28,651
Operating Segments [Member] | Hain Pure Protein [Member] | As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		141,706		265,694
Operating Income		18,125		28,396
Operating Segments [Member] | Hain Pure Protein [Member] | Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		2,486		1,553
Operating Income		37		255
Operating Segments [Member] | Rest of World [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		93,306		174,492
Operating Income	7,477	7,091	12,532	9,514
Operating Segments [Member] | Rest of World [Member] | As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		93,779		177,039
Operating Income		6,595		9,268
Operating Segments [Member] | Rest of World [Member] | Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		(473)		(2,547)
Operating Income		496		246
Corporate and Other [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating Income	$ (18,867)	(4,540)	$ (35,766)	(14,529)
Corporate and Other [Member] | As Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating Income		(4,081)		(13,649)
Corporate and Other [Member] | Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating Income		$ (459)		$ (880)

Earnings Per Share (Computation

Earnings Per Share (Computation Of Basic And Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Earnings Per Share [Abstract]
Net income	$ 27,185	$ 58,080	$ 35,789	$ 87,238
Denominator (in thousands):
Basic earnings per share - weighted average shares outstanding during the period (shares)	103,597	103,017	103,532	102,912
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units (shares)	607	1,144	693	1,297
Diluted earnings per share - adjusted weighted average shares and assumed conversions (shares)	104,204	104,161	104,225	104,209
Net income per common share:
Basic (USD per share)	$ 0.26	$ 0.56	$ 0.35	$ 0.85
Diluted (USD per share)	$ 0.26	$ 0.56	$ 0.34	$ 0.84

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - shares	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Stock Based Awards [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from computation of earnings per share			275,000	59,000
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from computation of earnings per share	27,000	0	27,000	0

Acquisitions (Fiscal 2016) (Nar

Acquisitions (Fiscal 2016) (Narrative) (Details) € in Thousands, shares in Thousands, $ in Thousands	Sep. 15, 2016GBP (£)	Dec. 21, 2015GBP (£)	Dec. 21, 2015USD ($)	Jul. 24, 2015USD ($)shares	Jul. 24, 2015EUR (€)shares	Dec. 31, 2015USD ($)	Dec. 31, 2016GBP (£)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Business Acquisition [Line Items]
Acquisition related costs | $						$ 1,948		$ 253	$ 2,961
Cash paid | $								$ 0	$ 157,061
Amount paid to sellers in settlement | £							£ (2,498,000)
Orchard House [Member]
Business Acquisition [Line Items]
Cash paid		£ 76,923,000	$ 114,113
Business combination, contingent consideration | £		£ 3,000,000
Amount paid to sellers in settlement | £	£ 1,500,000
Mona [Member]
Business Acquisition [Line Items]
Cash paid				$ 24,948	€ 22,753
Equity interest issued in business combination (shares) | shares				240	240
Equity issued | $				$ 16,308
Debt assumed in business combination | €					€ 16,252

Acquisitions (Pro Forma Results

Acquisitions (Pro Forma Results) (Details) - FY'16 Acquisitions [Member] - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 31, 2015	Dec. 31, 2015
Business Acquisition [Line Items]
Net sales	$ 780,746	$ 1,501,551
Net income	$ 57,721	$ 91,055
Net income per diluted common share (USD per share)	$ 0.55	$ 0.87

Inventories (Components Of Inve

Inventories (Components Of Inventories) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Inventory, Net [Abstract]
Finished goods	$ 266,675	$ 238,184
Raw materials, work-in-progress and packaging	163,903	170,380
Total inventories	$ 430,578	$ 408,564

Property, Plant And Equipment47

Property, Plant And Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Jun. 30, 2016
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 595,021		$ 595,021		$ 602,233
Less: Accumulated depreciation and amortization	222,939		222,939		212,392
Property, plant and equipment, net	372,082		372,082		389,841
Depreciation expense	9,888	$ 20,116	9,286	$ 18,389
Land [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	32,634		32,634		35,825
Buildings and improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	106,274		106,274		102,086
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	346,388		346,388		358,362
Computer hardware and software [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	48,357		48,357		48,829
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	14,072		14,072		14,165
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	27,800		27,800		28,471
Construction in progress [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 19,496		$ 19,496		$ 14,495

Goodwill And Other Intangible48

Goodwill And Other Intangible Assets (Changes In Carrying Amount Of Goodwill) (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Jun. 30, 2016
Goodwill
Goodwill	$ 1,060,336
Reallocation of goodwill between reporting units	0
Translation and other adjustments, net	(32,676)
Goodwill	1,027,660
Accumulated impairment charge	126,577	$ 126,577
United States [Member]
Goodwill
Goodwill	605,702
Reallocation of goodwill between reporting units	(16,377)
Translation and other adjustments, net	(2,431)
Goodwill	586,894
United Kingdom [Member]
Goodwill
Goodwill	332,561
Reallocation of goodwill between reporting units	0
Translation and other adjustments, net	(27,135)
Goodwill	305,426
Accumulated impairment charge	97,358	97,358
Hain Pure Protein [Member]
Goodwill
Goodwill	41,089
Reallocation of goodwill between reporting units	0
Translation and other adjustments, net	0
Goodwill	41,089
Rest of World [Member]
Goodwill
Goodwill	80,984
Reallocation of goodwill between reporting units	16,377
Translation and other adjustments, net	(3,110)
Goodwill	94,251
Europe [Member]
Goodwill
Accumulated impairment charge	$ 29,219	$ 29,219

Goodwill And Other Intangible49

Goodwill And Other Intangible Assets (Narrative) (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2016	Jun. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Non-cash partial impairment charge	$ 0	$ 0
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	3 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	25 years
United Kingdom [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment of long-lived assets		82,614,000
Orchard House [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment charge		1,934,000
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Non-cash partial impairment charge		39,724,000
Trade Names [Member] | United Kingdom [Member]
Finite-Lived Intangible Assets [Line Items]
Non-cash partial impairment charge		20,932,000
Trade Names [Member] | United States [Member]
Finite-Lived Intangible Assets [Line Items]
Non-cash partial impairment charge		$ 18,792,000

Goodwill And Other Intangible50

Goodwill And Other Intangible Assets (Components Of Trademarks And Other Intangible Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Indefinite-lived Intangible Assets [Line Items]
Trademarks and tradenames	$ 423,815	$ 441,140
Other intangibles	231,253	245,040
Less: accumulated amortization	(87,162)	(81,393)
Net carrying amount	567,906	604,787
Trademarks and Tradenames [Member]
Indefinite-lived Intangible Assets [Line Items]
Accumulated impairment	$ 46,123	$ 46,123

Goodwill And Other Intangible51

Goodwill And Other Intangible Assets (Amortization Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 4,693	$ 4,704	$ 9,421	$ 9,343

Debt and Borrowings (Schedule o

Debt and Borrowings (Schedule of Debt Balances) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Debt Instrument [Line Items]
Other borrowings	$ 7,017	$ 15,703
Long-term debt	803,060	862,684
Short-term borrowings and current portion of long-term debt	12,369	26,513
Long-term debt, less current portion	790,691	836,171
Credit Agreement borrowings payable to banks [Member]
Debt Instrument [Line Items]
Borrowings outstanding under credit agreement	783,911	827,860
Tilda short-term borrowing arrangements [Member]
Debt Instrument [Line Items]
Borrowings outstanding under credit agreement	$ 12,132	$ 19,121

Debt and Borrowings (Narrative)

Debt and Borrowings (Narrative) (Details)	Dec. 12, 2014USD ($)	Dec. 31, 2016GBP (£)	Dec. 31, 2016USD ($)	Dec. 31, 2016EUR (€)
Line of Credit Facility [Line Items]
Line of credit potential incremental borrowing capacity post-amendment	$ 350,000,000
Revolving credit facility expiration date	Dec. 12, 2019
Interest Coverage Ratio	4
Leverage ratio	3.50
Consolidated leverage ratio	4
Credit Agreement borrowings payable to banks [Member]
Line of Credit Facility [Line Items]
Revolving credit facility	$ 1,000,000,000
Letters of credit outstanding			$ 783,911,000
Remaining borrowing capacity			$ 209,909,000
Long-term debt, weighted average interest rate		1.98%	1.98%	1.98%
Credit Agreement borrowings payable to banks [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Unused capacity, commitment fee, percentage	0.20%
Credit Agreement borrowings payable to banks [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Unused capacity, commitment fee, percentage	0.30%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Letters of credit outstanding			$ 6,180,000
Eurocurrency Rate [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.875%
Eurocurrency Rate [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	1.70%
Base Rate [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.00%
Base Rate [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.70%
Tilda short-term borrowing arrangements [Member]
Line of Credit Facility [Line Items]
Revolving credit facility | £		£ 52,000,000
Debt instrument, term		6 months
Short-term debt, weighted average interest rate		2.80%	2.80%	2.80%
Mona [Member]
Line of Credit Facility [Line Items]
Revolving credit facility | €				€ 12,500,000
Short-term debt, weighted average interest rate		1.10%	1.10%	1.10%

Income Taxes Income Taxes (Narr

Income Taxes Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Effective income tax rate from continuing operations	27.90%		28.00%	24.10%	29.20%
Impact of reduction in UK statutory tax rate	$ 4,400	$ 2,086
Tax settlement				$ 1,200

Accumulated Other Comprehensi55

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net change in accumulated other comprehensive loss	$ (51,251)	$ (25,927)	$ (83,422)	$ (64,674)
Foreign currency translation adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(51,222)	(25,655)	(82,958)	(65,587)
Deferred gains/(losses) on cash flow hedging instruments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	45	1,118	101	3,271
Amounts reclassified into income	(55)	(1,414)	(506)	(2,226)
Reclassification from accumulated other comprehensive income	530	1,862	1,150	2,946
Unrealized gain/(loss) on available for sale investment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(19)	24	(69)	(132)
Amounts reclassified into income	0	0	10	0
Reclassification from accumulated other comprehensive income			16
Intra-entity foreign currency transactions [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	$ 12,908	$ 16,076	$ 20,061	$ 41,811

Stock Based Compensation And 56

Stock Based Compensation And Incentive Performance Plans (Stock Plans Narrative) (Details)	6 Months Ended
	Dec. 31, 2016USD ($)plan
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Number of plans | plan	2
Unrecognized compensation expense, stock options | $	$ 0

Stock Based Compensation And 57

Stock Based Compensation And Incentive Performance Plans (Compensation Cost And Related Income Tax Benefits Recognized) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Compensation cost (included in selling, general and administrative expense)	$ 2,531	$ 4,023	$ 5,235	$ 7,229
Related income tax benefit	$ 949	$ 1,499	$ 1,963	$ 2,710

Stock Based Compensation And 58

Stock Based Compensation And Incentive Performance Plans (Summary Of Stock Option Activity) (Details) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Number of Options
Options outstanding and exercisable at June 30, 2016 (shares) | shares	342
Exercised (shares) | shares	(220)
Options outstanding and exercisable at September 30, 2016 (shares) | shares	122
Weighted Average Exercise Price
Options outstanding and exercisable at June 30, 2016 (USD per share) | $ / shares	$ 6.66
Exercised (USD per share) | $ / shares	9.10
Options outstanding and exercisable at September 30, 2016 (USD per share) | $ / shares	$ 2.26
Weighted Average Contractual Life (years)	14 years 6 months
Aggregate Intrinsic Value | $	$ 4,484

Stock Based Compensation And 59

Stock Based Compensation And Incentive Performance Plans (Tax Benefit Recognized From Stock Option Exercises) (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Intrinsic value of options exercised	$ 6,507	$ 0
Tax benefit recognized from stock option exercises	$ 2,538	$ 0

Stock Based Compensation And 60

Stock Based Compensation And Incentive Performance Plans (Non-Vested Restricted Stock And Restricted Share Unit Awards) (Details) shares in Thousands	6 Months Ended
	Dec. 31, 2016$ / sharesshares
Number of Shares and Units
Non-vested restricted stock, restricted share units, and performance units at June 30, 2016 (shares) | shares	1,121
Vested (shares) | shares	(267)
Forfeited (shares) | shares	(14)
Non-vested restricted stock, restricted share units, and performance units at September 30, 2016 (shares) | shares	840
Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock, restricted share units, and performance units at June 30, 2016 (USD per share) | $ / shares	$ 28.24
Vested (USD per share) | $ / shares	32.37
Forfeited (USD per share) | $ / shares	33.14
Non-vested restricted stock, restricted share units, and performance units at September 30, 2016 (USD per share) | $ / shares	$ 27.28

Stock Based Compensation And 61

Stock Based Compensation And Incentive Performance Plans (Restricted Stock Grant Information) (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value of restricted stock, restricted share units, and performance units granted	$ 0	$ 9,660
Fair value of shares vested	9,004	17,855
Tax benefit recognized from restricted shares vesting	$ 3,464	$ 6,743

Stock Based Compensation And 62

Stock Based Compensation And Incentive Performance Plans (CEO July 2012 Grant) (Details) $ / shares in Units, $ in Thousands	Jul. 03, 2012USD ($)tranchetarget$ / sharesshares	Dec. 31, 2016USD ($)condition	Dec. 31, 2015USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Total Fair Value | $		$ 0	$ 9,660
Unrecognized stock-based compensation expense | $		$ 10,883
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Weighted Average Period to Recognize Expense		1 year 3 months
CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Total Shares (shares) | shares	800,000
Number of share price targets | target	4
Consecutive trading days	45 days
Vesting period	5 years
CEO Grant July 2012 Total Fair Value | $	$ 16,151
CEO Grant July 2012 Weighted Average Period to Recognize Expense	4 years
Number of market conditions | condition		4
Number of tranches | tranche	4
CEO [Member] | Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Total Shares (shares) | shares	200,000
CEO Grant July 2012 Market Price Target (USD per share)	$ 31.25
CEO [Member] | Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Market Price Target (USD per share)	36.25
CEO [Member] | Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Market Price Target (USD per share)	41.25
CEO [Member] | Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Market Price Target (USD per share)	$ 50

Stock Based Compensation And 63

Stock Based Compensation And Incentive Performance Plans (Long-Term Incentive Plan) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other labor-related expenses	$ 1,128	$ 4,069	$ 2,255	$ 4,290
Long Term Incentive Plan 2015-2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period			2 years
Long Term Incentive Plan 2016-2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period			3 years
Conversion of common stock (in shares)					1

Investments And Joint Ventures

Investments And Joint Ventures (Equity Method Investments) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016	Oct. 27, 2015
Hutchison Hain Organic Holdings Limited [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage	50.00%	50.00%
Advances to affiliate	$ 948	$ 1,729
Chop't [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage			14.90%
Equity method investments	$ 17,222	$ 17,448
Percentage diluted basis	12.10%

Investments And Joint Venture65

Investments And Joint Ventures (Available for Sale Securities) (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Jun. 30, 2016
Equity Method Investments and Joint Ventures [Abstract]
Equity ownership, less than	1.00%
Shares sold in period (in shares)	81,000	0
Gross realized gain (loss)		$ (16)
Remaining shares (in shares)	955,000
Available for sale securities	$ 877		$ 1,067
Amortized cost basis	$ 1,190		$ 1,291

Financial Instruments Measure66

Financial Instruments Measured At Fair Value (Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 47,609	$ 20,706
Forward foreign currency contracts	52	531
Available for sale securities	877	1,067
Assets total	48,538	22,304
Contingent consideration, current	1,702	3,553
Liabilities total	1,702	3,553
Quoted Prices In Active Markets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	47,609	20,706
Forward foreign currency contracts	0	0
Available for sale securities	877	1,067
Assets total	48,486	21,773
Contingent consideration, current	0	0
Liabilities total	0	0
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Forward foreign currency contracts	52	531
Available for sale securities	0	0
Assets total	52	531
Contingent consideration, current	0	0
Liabilities total	0	0
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Forward foreign currency contracts	0	0
Available for sale securities	0	0
Assets total	0	0
Contingent consideration, current	1,702	3,553
Liabilities total	$ 1,702	$ 3,553

Financial Instruments Measure67

Financial Instruments Measured At Fair Value (Narrative) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Jun. 30, 2016
Business Acquisition [Line Items]
Contingent consideration	$ 1,702,000		$ 1,702,000		$ 3,553,000
Notional amount	3,155,000		3,155,000		6,000,000
Fair value amounts of foreign exchange derivative contracts, net assets (liabilities)	52,000		$ 52,000		$ 531,000
Foreign exchange contracts, maturities			6 months
Discontinued foreign exchange hedges	$ 0	$ 0	$ 0	$ 0

Financial Instruments Measure68

Financial Instruments Measured At Fair Value (Summary Of Level 3 Activity) (Details) - 6 months ended Dec. 31, 2016 £ in Thousands, $ in Thousands	GBP (£)	USD ($)
Level 3 Activity
Balance as of June 30, 2016		$ 3,553
Contingent consideration adjustment and accretion of interest expense, net | £	£ 526
Contingent consideration paid | £	£ (2,498)
Translation adjustment		121
Balance as of December 31, 2016		$ 1,702

Commitments And Contingencies (

Commitments And Contingencies (Details)	Apr. 26, 2017complaint	Oct. 17, 2016plaintiff	Aug. 17, 2016complaint	Dec. 29, 2016complaint
Securities Complaints [Member]
Loss Contingencies [Line Items]
Number of complaints			3
Number of plaintiffs | plaintiff		6
Derivative Complaints [Member]
Loss Contingencies [Line Items]
Number of complaints				2
Barnes Complaint [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of complaints	2

Segment Information (Segment Da

Segment Information (Segment Data) (Details) $ in Thousands	Jul. 01, 2016segment	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Jun. 30, 2016segment
Segment Reporting Information [Line Items]
Number of operating segments | segment	8					7
Operating income (loss)		$ 41,400	$ 90,078	$ 55,151	$ 144,350
Acquisition and restructuring charges		7,113	2,498	13,534	4,591
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales		739,999	743,437	1,421,463	1,411,164
Operating income (loss)		60,267	94,618	90,917	158,879
Operating Segments [Member] | United States [Member]
Segment Reporting Information [Line Items]
Net sales		298,127	314,685	573,734	617,316
Operating income (loss)		42,552	50,940	64,615	92,447
Operating Segments [Member] | United Kingdom [Member]
Segment Reporting Information [Line Items]
Net sales		192,825	191,254	391,601	352,109
Operating income (loss)		6,697	18,425	11,247	28,267
Operating Segments [Member] | Hain Pure Protein [Member]
Segment Reporting Information [Line Items]
Net sales		152,979	144,192	269,648	267,247
Operating income (loss)		3,541	18,162	2,523	28,651
Operating Segments [Member] | Rest of World [Member]
Segment Reporting Information [Line Items]
Net sales		96,068	93,306	186,480	174,492
Operating income (loss)		7,477	7,091	12,532	9,514
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Operating income (loss)		$ (18,867)	$ (4,540)	$ (35,766)	$ (14,529)

Segment Information (Long-lived

Segment Information (Long-lived Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Segment Reporting Information [Line Items]
Long-lived assets	$ 422,987	$ 442,723
United States [Member]
Segment Reporting Information [Line Items]
Long-lived assets	196,522	193,192
United Kingdom [Member]
Segment Reporting Information [Line Items]
Long-lived assets	174,460	196,271
All Other [Member]
Segment Reporting Information [Line Items]
Long-lived assets	$ 52,005	$ 53,260

Segment Information (Net Sales)

Segment Information (Net Sales) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 739,999	$ 743,437	$ 1,421,463	$ 1,411,164
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	446,412	457,882	832,180	878,512
United Kingdom [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	212,312	211,380	432,463	393,531
All Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 81,275	$ 74,175	$ 156,820	$ 139,121